Vistin Pharma ASA (0RAM.L)

24.30 +0.40 (+1.67%) At close: 09:05AM BST

Vistin Pharma ASA

OestensjOeveien 27
Oslo 0661
Norway
47 35 98 42 00
https://www.vistin.com

Sector(s): 
Industry: 
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Magnus Tolleshaug	CEO, Chief Commercial Officer & Commercial Director	2.5M	N/A	N/A
Mr. Alexander Karlsen	Chief Financial Officer	2.51M	N/A	N/A
Mr. Vegard Heggem	Vice President of Operations	2.28M	N/A	N/A
Eivind Egeli	Director of Technical Service & Sales	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in NOK.

Description

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.

Corporate governance

Vistin Pharma ASA’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.